Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -240,416 | -149,490 | -67,501 | -133,969 | -64,172 |
| Depreciation Amortization | 35,917 | 23,204 | 11,234 | 53,082 | 45,653 |
| Income taxes - deferred | 14,629 | -14,951 | -7,800 | -25,617 | -12,373 |
| Accounts receivable | 146 | -37,587 | -26,789 | -25,951 | -3,482 |
| Other Working Capital | -74,970 | -90,365 | -97,375 | -15,884 | -30,273 |
| Other Operating Activity | 111,042 | 118,387 | 50,420 | 77,917 | 18,132 |
| Operating Cash Flow | $-153,652 | $-150,802 | $-137,811 | $-70,422 | $-46,515 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -581,087 | -575,063 | -164,294 | 301,277 | -241,462 |
| PPE Investments | -136,344 | -79,288 | -43,832 | -117,062 | -89,295 |
| Net Acquisitions | -538,392 | -538,392 | -538,392 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | 67,500 | 67,500 |
| Other Investing Activity | -3,326 | -3,326 | -4,353 | 12,112 | 64,400 |
| Investing Cash Flow | $-1,259,149 | $-1,196,069 | $-750,871 | $196,327 | $-266,357 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 939,772 | 933,684 | 916,283 | 197,368 | 155,099 |
| Other Financing Activity | -23,567 | -21,244 | -1,492 | -13,170 | -12,423 |
| Financing Cash Flow | $916,205 | $912,440 | $914,791 | $184,198 | $142,676 |
| Exchange Rate Effect | -2,544 | -391 | -1,025 | -3,398 | -580 |
| Beginning Cash Position | 875,486 | 875,486 | 875,486 | 568,781 | 568,781 |
| End Cash Position | 376,346 | 440,664 | 900,570 | 875,486 | 398,005 |
| Net Cash Flow | $-499,140 | $-434,822 | $25,084 | $306,705 | $-170,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153,652 | -150,802 | -137,811 | -70,422 | -46,515 |
| Capital Expenditure | -136,344 | -79,288 | -43,832 | -117,062 | -89,295 |
| Free Cash Flow | -289,996 | -230,090 | -181,643 | -187,484 | -135,810 |